News for Healthier Living

Direct-to-consumer pharmacies could save commercially insured patients 85% on high-cost generic drugs

A report comparing the Mark Cuban Cost Plus Drug Company (MCCPDC) to copayments or coinsurance under employer-sponsored insurance found that patients with high-cost generic prescriptions could lower their out-of-pocket costs from $140 to $25 by bypassing their insurance and using MCCPDC.

May 25, 2026


May 27 2026

May 26 2026

May 25 2026

May 22 2026

May 21 2026

May 20 2026

May 19 2026

May 18 2026

May 17 2026

May 16 2026

May 15 2026

May 14 2026

May 13 2026